Antidepressant-like drug effects in juvenile and adolescent mice in the tail suspension test: Relationship with hippocampal serotonin and norepinephrine transporter expression and function

Frontiers in Pharmacology

Volumn 4, Issue OCT, 2013, Pages 1-9

  Mitchell, Nathan C ^a   Gould, Georgianna G ^b   Smolik, Corey M ^a,b   Koek, Wouter ^b   Daws, Lynette C ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Adolescent; Antidepressant; Depression; Juvenile; Norepinephrine transporter; Selective serotonin reuptake inhibitor; serotonin transporter; Tricyclic

Indexed keywords

CITALOPRAM; DESIPRAMINE; ESCITALOPRAM; NISOXETINE; NORADRENALIN TRANSPORTER; SEROTONIN TRANSPORTER;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BINDING AFFINITY; BRAIN HOMOGENATE; C57BL 6 MOUSE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; IMMOBILITY; JUVENILE ANIMAL; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TAIL SUSPENSION TEST; YOUNG ADULT;

EID: 84925442952     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2013.00131     Document Type: Article

References (35)

1. Andreasen, J. T., and Redrobe, J. P. (2009). Antidepressant-like effects of nicotine and mecamylamine in the mouse forced swim and tail suspension tests: role of strain, test and sex. Behav. Pharmacol. 20, 286-295. doi: 10.1097/FBP.0b013e32832c713e
2. Bourin, M., Colombel, M. C., Redrobe, J. P., Nizard, J., Hascoët, M., and Baker, G. B. (1998). Evaluation of efficacies of different classes of antidepressants in the forced swimming test in mice at different ages. Prog. Neuropsychopharmacol. Biol. Psychiatry 22, 343-351. doi: 10.1016/S0278-5846(98)00009-8
3. Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., et al. (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized control trials. JAMA 297, 1683-1696. doi: 10.1001/jama.297.15.1683
4. Bujoreanu, S., Benhayon, D., and Szigethy, E. (2011). Treatment of depression in children and adolescents. Pediatr. Ann. 40, 548-555. doi: 10.3928/00904481-20111007-05
5. Bylund, D. B., and Reed, A. L. (2007). Childhood and adolescent depression: why do children and adults respond differently to antidepressant drugs? Neurochem. Int. 51, 246-253. doi: 10.1016/j.neuint.2007.06.025
6. Campbell, S., and McQueen, G. (2004). The role of the hippocampus in the pathophysiology of major depression. J. Psychiatr. Neurosci. 29, 417-426.
7. Castagne, V., Moser, P., Roux, S., and Porsolt, R. D. (2011). Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice. Curr. Protoc. Neurosci. Chapter 8, Unit 8.10A. doi: 10.1002/0471142301.ns0810as55
8. Csölle, C., Baranyi, M., Zsilla, G., Kittel, A., Gölöncsér, F., Illes., et al. (2013). Neurochemical changes in the mouse hippocampus underlying the antidepressant effect of genetic deletion of P2X7 receptors. PLoS ONE 8:e66547. doi: 10.1371/journal.pone.0066547
9. Cryan, J. F., and Holmes, A. (2005). The ascent of mouse: advances in modeling human depression and anxiety. Nat. Rev. Drug Discov. 4, 775-790. doi: 10.1038/nrd1825
10. Cryan, J. F., Mombereau, C., and Vassout, A. (2005). The tail suspension test a model for assessing antidepressant activity: review of pharmacological studies in mice. Neurosci. Biobehav. Rev. 29, 571-625. doi: 10.1016/j.neubiorev.2005.03.009
11. D'Amato, R. J., Largent, B. L., Snowman, A. M., and Snyder, S. H. (1987). Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine. J. Pharmacol. Exp. Ther. 242, 364-371.
12. David, D. J. P., Bourin, M., Hascoët, M., Colombel, M. C., Baker, G. B., and Jolliet, P. (2001a). Comparison of antidepressant activity in 4- and 40-week-old male mice in the forced swimming test: involvment of 5-HT1A and 5-HT1B receptors in old mice. Psychopharmacology 153, 443-449. doi: 10.1007/s002130000588
13. David, D. J. P., Dhonnchadha, B. A. N., Jolliet, P., Hascoët, M., and Bourin, M. (2001b). Are there gender differences in the temperature profile of mice after acute antidepressant administration and exposure to tow animal models of depression. Behav. Brain Res. 119, 203-211. doi: 10.1016/S0166-4328(00)00351-X
14. Daws, L. C., and Gould, G. G. (2011). Ontogeny and regulation of the serotonin transporter: providing insight into human disorders. Pharmacol. Ther. 131, 61-79. doi: 10.1016/j.pharmthera.2011.03.013
15. Galineau, L., Kodas, E., Guilloteau, D., Vilar, M. P., and Chalon, S. (2004). Ontogeny of the dopamine and serotonin transporters in the rat brain: an autoradiographic study. Neurosci. Lett. 363, 266-271. doi: 10.1016/j.neulet.2004.04.007
16. Gould, G. G., Hensler, J. G., Burke, T. F., Benno, R. H., Onaivi, E. S., and Daws, L. C. (2011). Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior. J. Neurochem. 116, 291-303. doi: 10.1111/j.1471-4159.2010.07104.x
17. Hazell, P., and Mirzaie, M. (2013). Tricyclic drugs for depression in children and adolescents. Cochrane Database Syst. Rev. 6. doi: 10.1002/14651858.CD002317.pub2
18. Hazell, P., O'Connell, D., Heathcote, D., Robertson, J., and Henry, D. (1995). Efficacy of tricylcic drugs in treating child and adolescent depression: a meta-analysis. BMJ 310, 897-901. doi: 10.1136/bmj.310.6984.897
19. Hetrick, S. E., McKenzie, J. E., and Merry, S. N. (2010). The use of SSRIs in children and adolescents. Curr. Opin. Psychiatr. 23, 53-57. doi: 10.1097/YCO.0b013e328334bc92
20. Hetrick, S. E., Merry, S. N., McKenzie, J., Sindahl, P., and Proctor, M. (2009). Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents (Review). Cochrane Database Syst. Rev. 1-91.
21. Jones, M. D., and Lucki, I. (2005). Sex differences in the regulation of serotonergic transmission and behavior in 5-HT receptor knockout mice. Neuropsychopharmacology 30, 1039-1047. doi: 10.1038/sj.npp.1300664
22. Kessler, R. C., Avenevoli, S., and Reis Merikangas, K. (2001). Mood disorders in children and adolescents: an epidemiologic perspective. Biol. Psychiatry 49, 1002-1014. doi: 10.1016/S0006-3223(01)01129-5
23. Kratochvil, C., Emslie, G., Silva, S., McNulty, S., Walkup, J., Curry, J., et al. (2006). Acute time to response in the Treatment of Adolescents with Depression Study (TABS). J. Am. Acad. Child Adolesc. Psychiatry 45, 1412-1418. doi: 10.1097/01.chi.0000237710.73755.14
24. Mason, S. S., Baker, K. B., Davis, K. W., Pogorelov, V. M., Malbari, M. M., Ritter, R., et al. (2009). Differential sensitivity to SSRI and tricyclic antidepressants in juvenile and adult mice of three strains. Eur. J. Pharmacol. 602, 306-315. doi: 10.1016/j.ejphar.2008.11.010
25. Murrin, L. C., Sander, J. D., and Bylund, D. B. (2007). Comparison of the maturation of the adrenergic and serotonergic neurotransmitter systems in the brain: implications for differential drug effects on juveniles and adults. Biochem. Pharmacol. 73, 1225-1236. doi: 10.1016/j.bcp.2007.01.028
26. O'Leary, O. F., Bechtholt, A. J., Crowley, J. J., Hill, T. E., Page, M. E., and Lucki, I. (2007). Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. Psychopharmacology 192, 357-371. doi: 10.1007/s00213-007-0728-9
27. Pechnick, R. N., Bresee, C. J., Manalo, C. M., and Poland, R. E. (2008). Comparison of the effects of desmethylimipramine on behavior in the forced swim test in peripubertal and adult rats. Behav. Pharmacol. 19, 81-84. doi: 10.1097/FBP.0b013e3282f3d07f
28. Reed, A. L., Happe, H. K., Petty, F., and Bylund, D. B. (2008). Juvenile rats in the forced-swim test model the human response to antidepressant treatment for pediatric depression. Psychopharmacology 197, 433-441. doi: 10.1007/s00213-007-1052-0
29. Sanchez, C., Bergqvist, P. B. F., Brennum, L. T., Gupta, S., Hogg, S., Larsen, A., et al. (2003). Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities. Psychopharmacology 167, 353-362.
30. Sanders, J. D., Happe, H. K., Bylund, D. B., and Murrin, L. C. (2005). Development of the norepinephrine transporter in the rat CNS. Neuroscience 130, 107-117. doi: 10.1016/j.neuroscience.2004.09.014
31. Spear, L. P. (2000). The adolescent brain and age-related behavioral manifestations. Neurosci. Behav. Rev. 24, 417-463. doi: 10.1016/S0149-7634(00)00014-2
32. Steru, L., Chermat, R., Thierry, B., and Simon, P. (1985). The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85, 367-370. doi: 10.1007/BF00428203
33. Tejani-Butt, S. (1992). [3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or homogenate binding. J. Pharmacol. Exp. Ther. 260, 427-436.
34. Tsapakis, E. M., Soldani, F., Tondo, L., and Baldessarini, R. J. (2008). Efficacy of antidepressants in juvenile depression: meta-analysis. Br. J. Psychiatry 193, 10-17. doi: 10.1192/bjp.bp.106.031088
35. Zhou, F. C., Sari, Y., and Zhang, J. K. (2000). Expression of serotonin transporter protein in developing rat brain. Brain Res. Dev. Brain Res. 119, 33-45. doi: 10.1016/S0165-3806(99)00152-2